LMO2 and breast cancer: Additionally, potential LMO2 functions on other breast cancer subtypes were also investigated in the TCGA dataset and interestingly, high LMO2 expression was found to predict a shorter overall survival in luminal A-type whereas a better outcome in Her2-type (Supplementary Figure 1D).